INVITRO TOPOGRAPHICAL CHARACTERIZATION AS A PREDICTOR OF INVIVO CONTROLLED RELEASE QUINIDINE GLUCONATE BIOAVAILABILITY

被引：22

作者：

SKELLY, JP ^{[1
]}

YAU, MK ^{[1
]}

ELKINS, JS ^{[1
]}

YAMAMOTO, LA ^{[1
]}

SHAH, VP ^{[1
]}

BARR, WH ^{[1
]}

机构：

[1] US FDA,DIV BIOPHARMACEUT,ROCKVILLE,MD 20857

来源：

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY | 1986年 / 12卷 / 8-9期

关键词：

D O I：

10.3109/03639048609065853

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：1177 / 1201

页数：25

共 11 条

[1] SERIOUS BIOAVAILABILITY PROBLEMS WITH A GENERIC PROLONGED-RELEASE QUINIDINE GLUCONATE PRODUCT [J].

MEYER, MC ;

STRAUGHN, AB ;

LIEBERMAN, P ;

JACOB, J .

JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (2-3) :131-134

[2]

PRASAD V, 1983, INT J PHARM, V13, P7

[3] INVITRO TOPOGRAPHICAL CHARACTERIZATION AS A PREDICTOR OF INVIVO CONTROLLED RELEASE QUINIDINE GLUCONATE BIOAVAILABILITY [J].

SKELLY, JP ;

YAU, MK ;

ELKINS, JS ;

YAMAMOTO, LA ;

SHAH, VP ;

BARR, WH .

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1986, 12 (8-9) :1177-1201

[4]

1973, DOCUMENTA GEIGY SCI, P281

[5]

[No title captured]

[6]

ANDA87448 FOOD DRUG

[7]

ANDA87810 FOOD DRUG

[8]

NDA16647 FOOD DRUG A

[9]

NDA17917 FOOD DRUG A

[10]

ANDA87785 FOOD DRUG

← 1 2 →